Impact of Bone Marrow Morphology on Multivariate Risk Classification in Chronic Myelogenous Leukemia
暂无分享，去创建一个
[1] V. Diehl,et al. Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] J. Hasford,et al. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group. , 1998, Journal of the National Cancer Institute.
[3] H. Heimpel,et al. Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score , 1997, British journal of haematology.
[4] J. Thiele,et al. Erythropoiesis in CML--immunomorphometric quantification, PCNA-reactivity, and influence on survival. , 1993, Hematologic pathology.
[5] E. Feliú,et al. Is the histological classification of chronic granulocytic leukaemia justified from the clinical point of view? , 1989, European journal of haematology.
[6] H. Kantarjian,et al. The relevance of reticulin stain‐measured fibrosis at diagnosis in chronic myelogenous leukemia , 1987, Cancer.
[7] Francisco Cervantes,et al. Prognostic discrimination in "good-risk" chronic granulocytic leukemia , 1984 .
[8] D. Bauermeister. Quantitation of bone marrow reticulin--a normal range. , 1971, American journal of clinical pathology.